Jefferies Assumes Coverage on LinkedIn (LNKD) at Buy; Looking For Near-Term Performance
Tweet Send to a FriendGet Alerts LNKD Hot Sheet
Price: $184.75 +1.34%
Rating Summary:
19 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Rating Summary:
19 Buy, 14 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 25 | New: 24
Trade LNKD Now!
Jefferies assumes coverage on LinkedIn (NYSE: LNKD) with a Buy. PT $142.00 (from $92.00).
Jefferies analyst said, "LNKD is likely to continue to perform in the near term, driven by: 1) a beat and raise earnings based on conservative guidance, and 2) an ability to keeping taking market share as it provides the most differentiated, effective products out there, in all three of its segments."
Lowers FY EPS estimate from $0.36 to (0.20) and next yr from $0.80 to $0.44.
For an analyst ratings summary and ratings history on LinkedIn click here. For more ratings news on LinkedIn click here.
Shares of LinkedIn closed at $107.37 yesterday, with a 52 week range of $55.98-$120.63.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Jefferies analyst said, "LNKD is likely to continue to perform in the near term, driven by: 1) a beat and raise earnings based on conservative guidance, and 2) an ability to keeping taking market share as it provides the most differentiated, effective products out there, in all three of its segments."
Lowers FY EPS estimate from $0.36 to (0.20) and next yr from $0.80 to $0.44.
For an analyst ratings summary and ratings history on LinkedIn click here. For more ratings news on LinkedIn click here.
Shares of LinkedIn closed at $107.37 yesterday, with a 52 week range of $55.98-$120.63.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
Create E-mail Alert Related Categories
Analyst EPS Change, Analyst EPS View, Analyst PT Change, New CoverageRelated Entities
Jefferies & Co, EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

